Skip to main content
Premium Trial:

Request an Annual Quote

David Allis and Phillip Sharp

Premium

The Wiley Foundation said this week that Rockefeller University researcher David Allis has been named the recipient of the third annual Wiley Prize in the Biomedical Sciences.

“David Allis has been selected to receive this year’s Wiley Prize in the Biomedical Sciences for his significant discovery that transcription factors can enzymatically modify histones to regulate gene activity,” Gunter Blobel, a Rockefeller researcher and chairman of the Wiley Prize awards jury, said in a statement.

According to the Wiley Foundation, Allis’ work focuses on the chemical modifications that control chromatin structure and function with an eye towards its role in cancer.

Last year’s winners of the Wiley Prize include Rockefeller’s Thomas Tuschl, Andrew Fire from the Carnegie Institute, Craig Mello from the University of Massachusetts Medical School, and David Baulcombe from the Sainsbury Laboratory at the John Innes Centre, for their work with RNA interference.


Massachusetts Institute of Technology said this week that Phillip Sharp, director of the McGovern Institute for Brain Research, has been named a member of the committee that will select the winner of the Edward M. Scolnick Prize.

The prize is given each year to recognize an outstanding discovery or significant advance in the field of neuroscience, said MIT. It was created in 2003 and named after the former president of Merck Research Laboratories.

The recipient(s) of the prize will present a public lecture at MIT and receive the award, equal to $50,000, at a ceremony in the spring.

The Scan

Not as High as Hoped

The Associated Press says initial results from a trial of CureVac's SARS-CoV-2 vaccine suggests low effectiveness in preventing COVID-19.

Finding Freshwater DNA

A new research project plans to use eDNA sampling to analyze freshwater rivers across the world, the Guardian reports.

Rise in Payments

Kaiser Health News investigates the rise of payments made by medical device companies to surgeons that could be in violation of anti-kickback laws.

Nature Papers Present Ginkgo Biloba Genome Assembly, Collection of Polygenic Indexes, More

In Nature this week: a nearly complete Ginkgo biloba genome assembly, polygenic indexes for dozens of phenotypes, and more.